When the authors investigated the effect of treatment with BMSC-EVs on PF in the BLM-fibrosis mouse model, they observed a decreased expression of α-SMA and collagen 1, which was increased after miR-186 expression in BMSCs. The gene discussed is ACTA1; the disease is fibrosis.